Tradestie Institutional Equity Comparison Engine

KRP vs VET โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

KRP Overall Edge

KRP Captures Institutional Edge (2โ€“2 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Kimbell Royalty Partners, LP Common Units representing Limited Partner Interests (KRP) driven by superior Valuation, Growth & Margin while VET counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, KRP trades at 14.4x Forward P/E with 38.0% operating margin (+28.9% YoY revenue) versus VET at 17.4x Forward P/E and -0.7% operating margin (+30.4% YoY). In options structure, KRP sits in UNCLASSIFIED (1st %ile IV; Dealer Gamma Walls on Pro) against VET sits in CONSOLIDATION (23rd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner KRP
KRP 14.4x vs VET 17.4x Fwd P/E
Growth & Margin Winner KRP
Op Margin 38.0% vs -0.7% ยท YoY +28.9% vs +30.4%
Momentum & Technical Winner VET
1Y +6.3% vs +11.3% ยท 52W Pos 47% vs 35%
Options & Structure Winner VET
UNCLASSIFIED (1st %ile IV) vs CONSOLIDATION (23rd %ile IV)
KRP NYSE
Kimbell Royalty Partners, LP Common Units representing Limited Partner Interests
Crude Petroleum & Natural Gas
$14.06
-0.57% 1D
Market Cap $2.1B
1M Return -14.68%
1Y Return +6.35%
Forward P/E 14.4x
Unified AI Score
54.6 / 100 HOLD
Tech 45.0 Fund 50.0 Flow 50.0 Mom 55.0
VET NYSE
Vermilion Energy Inc.
Crude Petroleum & Natural Gas
$10.25
-1.06% 1D
Market Cap $1.6B
1M Return -23.79%
1Y Return +11.29%
Forward P/E 17.4x
Unified AI Score
71.1 / 100 BUY
Tech 84.0 Fund 71.0 Flow 56.0 Mom 70.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: KRP +6.35% VET +11.29% Spread: +4.94 pp (VET Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
KRP TTM Op. Margin: 38.0% VET TTM Op. Margin: -0.7%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on KRP vs VET. Trailing 12-month operating profitability (KRP 38.0% vs VET -0.7%) and valuation multiples (KRP 14.4x vs VET 17.4x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: KRP (7) vs VET (3)
Institutional Metric KRP VET Criterion Row Winner
Market Capitalization Scale $2.1B $1.6B Larger Scale KRP
Trailing P/E Ratio Valuation 18.0x 17.4x Lower Multiple VET
Forward P/E Ratio Valuation 14.4x 17.4x Lower Multiple KRP
Revenue Growth (YoY) Growth +28.9% +30.4% Higher Growth VET
Operating Margin (TTM) Profitability 38.0% -0.7% Higher Margin KRP
Net Profit Margin Profitability 23.0% -24.6% Higher Margin KRP
Return on Equity (ROE) Capital Efficiency 11.2% -20.1% Higher ROE KRP
52-Week Range Position Momentum 47% ($11โ€“$17) 35% ($8โ€“$15) Stronger Trend KRP
Beta / 30D Volatility Risk Regime -0.29ฮฒ ยท 30% Vol -0.77ฮฒ ยท 61% Vol Lower Realized Risk KRP
Unified Institutional Score Composite Signal 54.6 / 100 (HOLD) 71.1 / 100 (BUY) Higher Composite VET

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full KRP vs VET Buy Guide
KRP UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 1st %ile
IV Regime Compressed (<25th %ile)
Live KRP Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
VET CONSOLIDATION
48d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 23rd %ile
IV Regime Compressed (<25th %ile)
Live VET Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither KRP nor VET registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.